Understanding the clonal architecture and evolutionary history of a tumour poses one of the key challenges to overcome treatment failure due to resistant cell populations. Previously, studies on subclonal tumour evolution have been primarily based on bulk sequencing and in some recent cases on single-cell sequencing data. Either data type alone has shortcomings with regard to this task, but methods integrating both data types have been lacking. Here, we present B-SCITE, the first computational approach that infers tumour phylogenies from combined single-cell and bulk sequencing data. Using a comprehensive set of simulated data, we show that B-SCITE systematically outperforms existing methods with respect to tree reconstruction accuracy and ...
Abstract Background High-throughput sequencing allows...
Single-cell sequencing provides a powerful approach for elucidating intratumor heterogeneity by reso...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
Subclonal architectures are prevalent across cancer types. However, the temporal evolutionary dynami...
Background: The large-scale availability of whole-genome sequencing profiles from bulk DNA sequencin...
Tumours are composed of multiple subpopulations, each of which has its own genotype and phenotype. ...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Thesis advisor: Gabor MarthUnlike normal tissue cells, which contain identical copies of the same ge...
Improving our understanding of intra-tumour heterogeneity in cancer has important clinical implicati...
Tumours are heterogeneous populations of cells that evolve dynamically in response to selective pres...
Genomic analysis provides insights into the role of copy number variation in disease, but most metho...
<div><p>Recent improvements in next-generation sequencing of tumor samples and the ability to identi...
Abstract Background High-throughput sequencing allows...
Single-cell sequencing provides a powerful approach for elucidating intratumor heterogeneity by reso...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...
Understanding the clonal architecture and evolutionary history of a tumour poses one of the key chal...
Cancer is a genetic disease characterized by the emergence of genetically distinct populations of ce...
Tumour development has long been recognised as an evolutionary process during which cells accumulate...
Subclonal architectures are prevalent across cancer types. However, the temporal evolutionary dynami...
Background: The large-scale availability of whole-genome sequencing profiles from bulk DNA sequencin...
Tumours are composed of multiple subpopulations, each of which has its own genotype and phenotype. ...
SummaryThe extensive genetic heterogeneity of cancers can greatly affect therapy success due to the ...
Thesis advisor: Gabor MarthUnlike normal tissue cells, which contain identical copies of the same ge...
Improving our understanding of intra-tumour heterogeneity in cancer has important clinical implicati...
Tumours are heterogeneous populations of cells that evolve dynamically in response to selective pres...
Genomic analysis provides insights into the role of copy number variation in disease, but most metho...
<div><p>Recent improvements in next-generation sequencing of tumor samples and the ability to identi...
Abstract Background High-throughput sequencing allows...
Single-cell sequencing provides a powerful approach for elucidating intratumor heterogeneity by reso...
The sensitivity of massively-parallel sequencing has confirmed that most cancers are oligoclonal, wi...